These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6420046)

  • 1. Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.
    la Cour Petersen E; Hokland P; Ellegaard J
    Cancer Immunol Immunother; 1983; 16(2):88-92. PubMed ID: 6420046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy and corynebacterium parvum for induction and maintenance of remission in acute myelogenous leukaemia--a controlled study.
    Shetty PA; Pai VR; Jani PH; Antia PK; Shahane AD
    Indian J Cancer; 1983; 20(2):119-23. PubMed ID: 6580265
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
    Eppinger-Helft M; Pavlovsky S; Hidalgo G; Muriel FS; Suárez A; Garay G; Russo C; Santos M; Macchi A; Lein J
    Cancer; 1980 Jan; 45(2):280-4. PubMed ID: 6985835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immunotherapy in acute myelogenous leukemia.
    Foon KA; Smalley RV; Riggs CW; Gale RP
    Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies in patients receiving Corynebacterium parvum (C.P.) as immunotherapy for acute myelogenous leukemia (AML).
    Pai VR; Shetty PA; Jussawalla DJ
    Indian J Cancer; 1982; 19(3):149-52. PubMed ID: 6959958
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized controlled study of chemoimmunotherapy of acute myelogenous leukemia (AML) in adults with Nocardia rubra cell-wall skeleton and irradiated allogeneic AML cells.
    Ohno R; Nakamura H; Kodera Y; Ezaki K; Yokomaku S; Oguma S; Kubota Y; Shibata H; Ogawa N; Masaoka T
    Cancer; 1986 Apr; 57(8):1483-8. PubMed ID: 3512070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
    Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
    Vogler WR; Winton EF; Gordon DS; Raney MR; Go B; Meyer L
    Blood; 1984 May; 63(5):1039-45. PubMed ID: 6201211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of Corynebacterium parvum adjuvant therapy following surgery for (stage II) malignant melanoma.
    Thatcher N; Mene A; Banerjee SS; Craig P; Gleave N; Orton C
    Br J Surg; 1986 Feb; 73(2):111-5. PubMed ID: 3512025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase-II trial of Corynebacterium parvum as adjuvant to surgery in the treatment of operable lung cancer.
    Woodruff M; Walbaum P
    Cancer Immunol Immunother; 1983; 16(2):114-6. PubMed ID: 6362846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with allogeneic neuraminidase-treated blasts for maintenance in acute myelogenous leukemia (AML). Significant prolongation of remission duration in patients receiving at least 3 cycles of therapy.
    Urbanitz D; Pielken HJ; Koch P; Büchner T; Hiddemann W; Heinecke A; Wendt F; Maschmeier G; van de Loo J
    Onkologie; 1985 Jun; 8(3):157-9. PubMed ID: 3895098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of NK and ADCC by Corynebacterium parvum in acute myeloid leukaemia patients.
    Hokland P; Ellegaard J
    Leuk Res; 1985; 9(1):175-84. PubMed ID: 3857405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy of acute myelogenous leukemia (AML) in adults with the Nocardia rubra cell wall skeleton].
    Ohno R; Nakamura H; Kodera Y; Masaoka T; Yamada K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1264-9. PubMed ID: 3524463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for remission maintenance in acute myeloblastic leukemia.
    Baker MA; Taub RN; Carter WH
    Cancer Immunol Immunother; 1982; 13(2):85-8. PubMed ID: 6760961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation.
    Ohno R; Yamada K; Masaoka T; Ohshima T; Amaki I; Hirota Y; Horikoshi N; Horiuchi A; Imai K; Kimura I
    Cancer Immunol Immunother; 1984; 18(3):149-54. PubMed ID: 6391658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase-treated allogeneic blasts for maintenance in acute myelogenous leukemia: results of a prospective randomized trial.
    Urbanitz D; Büchner T; Pielken H; Koch P; Ludwig WD; Maschmeier G; Heinecke A; van de Loo J
    Haematol Blood Transfus; 1987; 30():64-8. PubMed ID: 3305224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.
    Büchner T; Urbanitz D; Hiddemann W; Rühl H; Ludwig WD; Fischer J; Aul HC; Vaupel HA; Kuse R; Zeile G
    J Clin Oncol; 1985 Dec; 3(12):1583-9. PubMed ID: 3906048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Corynebacterium parvum immunotherapy for squamous cell epitheliomas of the oral cavity, pharynx, and larynx.
    Neifeld JP; Terz JJ; Kaplan AM; Lawrence W
    J Surg Oncol; 1985 Feb; 28(2):137-45. PubMed ID: 3881630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.